Young Matthew Stephen's Form 4 filing

Nutex Health Inc. (NUTX) · filed Dec 14, 2022

Accession no.: 0001062993-22-023884
Filed: Dec 14, 2022, 3:36 PM ET
Trade date: Dec 12-13, 2022
Filing delay: 2 days
Rule 10b5-1 plan: Not on the form (before 2023)

Original on SEC EDGAR (opens in a new tab)

This filing lists 2 non-derivative transactions. Open-market sales total $367.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
Owner	Relationship to the company
Young Matthew StephenCIK 0001920043	Director
Premier Macy Management Holdings, LLCCIK 0001920021	10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade date	Security	Transaction	Shares	Price	Value	Shares after	Ownership	Flags
Dec 12, 2022	Class A Common Stock	SSaleDisposed	−125,498	$2.21^F2	−$276,773.29	42,008,712	Direct
Dec 13, 2022	Class A Common Stock	SSaleDisposed	−43,880	$2.06^F4	−$90,559.54	41,964,832	Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.04 to $2.445, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.

Referenced by the price of 1 transaction in Table I.

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.04 to $2.12, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)